AAOS Clinical Practice Guideline: Preventing Venous Thromboembolic Disease in Patients Undergoing Elective Hip and Knee Arthroplasty

Abstract

From the Rubin Institute for Advanced Orthopedics and the Center for Joint Preservation and Replacement, Sinai Hospital of Baltimore, Baltimore, MD (Dr. Mont) and the Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL (Dr. Jacobs). Dr. Mont or an immediate family member has received royalties from Stryker; serves as a paid consultant to Johnson & Johnson, Joint Active Systems, Salient Surgical, Stryker, and TissueGene; and has received research or institutional support from National Institutes of Health (NIAMS and NICHD), Stryker, TissueGene, and Wright Medical Technology. Dr. Jacobs or an immediate family member serves as a paid consultant to Johnson & Johnson, Medtronic Sofamor Danek, Smith & Nephew, SpinalMotion, and Zimmer; serves as an unpaid consultant to Implant Protection; owns stock or stock options held in Implant Protection; and has received research or institutional support from Medtronic Sofamor Danek, SpinalMotion, and Zimmer.